Filing Details
- Accession Number:
- 0001447362-21-000213
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-07 17:26:11
- Reporting Period:
- 2021-09-02
- Accepted Time:
- 2021-09-07 17:26:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | Services-Medical Laboratories (8071) | 770701774 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1782994 | E. Bernhard Spiess | C/O Castle Biosciences, Inc. 505 S. Friendswood Drive, Ste. 401 Friendswood TX 77546 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-02 | 8,989 | $1.92 | 22,551 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-02 | 6,412 | $2.39 | 28,963 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-02 | 8,038 | $75.24 | 20,925 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-02 | 5,889 | $76.14 | 15,036 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-02 | 1,474 | $77.29 | 13,562 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2021-09-02 | 8,989 | $0.00 | 8,989 | $1.92 |
| Common Stock | Stock option (right to buy) | Disposition | 2021-09-02 | 6,412 | $0.00 | 6,412 | $2.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,889 | 2026-05-23 | No | 4 | M | Direct | |
| 2,304 | 2028-05-09 | No | 4 | M | Direct |
Footnotes
- These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 19, 2021.
- This transaction was executed in multiple trades at prices ranging from $74.59 to $75.58, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $75.60 to $76.45, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $76.70 to $77.63, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- 25% of the 169,592 shares originally subject to the option vested on May 2, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.
- 25% of the 12,305 shares originally subject to the option vested on May 10, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
